How AI Could Shorten the Drug Approval Timeline | Jesus Mantas at Davos 2026 @sandboxaq
How AI Could Shorten the Drug Approval Timeline | Jesus Mantas at Davos 2026  @sandboxaq
Uploaded February 2026 | Updated November 2026, 3 days ago
At Davos 2026, Bill Fitzgerald (VP of Growth & Ecosystems at SandboxAQ) speaks with Jesus Mantas, former IBM Consulting leader and biotech board member, about the convergence of AI and biology.

The discussion explores:
• How neural networks are transforming drug discovery
• Designing antibodies using AI
• Cell perturbation models and biological prediction
• Accelerating precision medicine
• Compressing regulatory timelines with AI
• Why data quality, not AI, is often the true bottleneck

As compute scales exponentially and models improve, AI may fundamentally reshape how medicines are discovered, validated, and delivered to patients.

Check out our Voices of Davos playlist for more exclusive interviews like this! youtube.com/playlist?list=PLMsyYLfyvI2H0E5dNwlP0qoI4s8Z8gdMK

Subscribe to stay updated on the latest breakthroughs in AI and quantum technology. Learn more about SandboxAQ’s innovative solutions at: sandboxaq.com

#sandboxaq #lqms
How AI Could Shorten the Drug Approval Timeline | Jesus Mantas at Davos 2026How AI Models Are Being Used in Scientific R&D | Jack Hidary on CNBCHow AI Learns: Gradient Descent Explained (Part 1/3)The Invisible Financial Crisis | Jack Hidary Op-Ed (Part 5/5)Why Animal Models Keep Failing in Human Trials | Jack Hidary at the Cures ConferenceWhy Multimodal AI Is Smarter Than Text Alone | Multimodal & Crossmodal AI Explained Part 1/5What is Post-Quantum Cryptography (PQC)? | Preparing for the Quantum ThreatThe Human Side of Science: Chasing the Unknown with Joe Howlett | fAQ podcast S3 E11Why AI Hallucinates (And How to Stop It) | Fast FAQtsSandboxAQ Culture | From Jack Hidary on theCUBE + NYSE WiredThe New Materials Race | Jack Hidary Op-Ed (Part 2/5)How Scientists Model Cells with Synthetic Data | Fast FAQts with Tiffany Callahan Part 2/3
SandboxAQ |

How AI Could Shorten the Drug Approval Timeline | Jesus Mantas at Davos 2026

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER